Biospecific Chemistry for Covalent Linking of Biomacromolecules

被引:14
作者
Cao, Li [1 ,2 ]
Wang, Lei [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Cardiovasc Res Inst, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA
关键词
PROTEIN CROSS-LINKING; RNA-BINDING PROTEINS; STRUCTURAL BASIS; CLICK CHEMISTRY; OPTICAL CONTROL; DRUG DISCOVERY; MESSENGER-RNA; AMINO-ACIDS; IN-VITRO; PROXIMITY;
D O I
10.1021/acs.chemrev.4c00066
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Interactions among biomacromolecules, predominantly noncovalent, underpin biological processes. However, recent advancements in biospecific chemistry have enabled the creation of specific covalent bonds between biomolecules, both in vitro and in vivo. This Review traces the evolution of biospecific chemistry in proteins, emphasizing the role of genetically encoded latent bioreactive amino acids. These amino acids react selectively with adjacent natural groups through proximity-enabled bioreactivity, enabling targeted covalent linkages. We explore various latent bioreactive amino acids designed to target different protein residues, ribonucleic acids, and carbohydrates. We then discuss how these novel covalent linkages can drive challenging protein properties and capture transient protein-protein and protein-RNA interactions in vivo. Additionally, we examine the application of covalent peptides as potential therapeutic agents and site-specific conjugates for native antibodies, highlighting their capacity to form stable linkages with target molecules. A significant focus is placed on proximity-enabled reactive therapeutics (PERx), a pioneering technology in covalent protein therapeutics. We detail its wide-ranging applications in immunotherapy, viral neutralization, and targeted radionuclide therapy. Finally, we present a perspective on the existing challenges within biospecific chemistry and discuss the potential avenues for future exploration and advancement in this rapidly evolving field.
引用
收藏
页码:8516 / 8549
页数:34
相关论文
共 198 条
[1]   Site-Specific Antibody-Drug Conjugates: The Nexus of Biciorthogonal Chemistry, Protein Engineering, and Drug Development [J].
Agarwal, Paresh ;
Bertozzi, Carolyn R. .
BIOCONJUGATE CHEMISTRY, 2015, 26 (02) :176-192
[2]   Therapeutic Targeting of Siglecs using Antioody- and Glycan-Based Approaches [J].
Angata, Takashi ;
Nycholat, Corwin M. ;
Macauley, Matthew S. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (10) :645-660
[3]   Structural details of a Class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in living cells [J].
Aydin, Yasmin ;
Bottke, Thore ;
Lam, Jordy Homing ;
Ernicke, Stefan ;
Fortmann, Anna ;
Tretbar, Maik ;
Zarzycka, Barbara ;
Gurevich, Vsevolod V. ;
Katritch, Vsevolod ;
Coin, Irene .
NATURE COMMUNICATIONS, 2023, 14 (01)
[4]   Accurate prediction of protein structures and interactions using a three-track neural network [J].
Baek, Minkyung ;
DiMaio, Frank ;
Anishchenko, Ivan ;
Dauparas, Justas ;
Ovchinnikov, Sergey ;
Lee, Gyu Rie ;
Wang, Jue ;
Cong, Qian ;
Kinch, Lisa N. ;
Schaeffer, R. Dustin ;
Millan, Claudia ;
Park, Hahnbeom ;
Adams, Carson ;
Glassman, Caleb R. ;
DeGiovanni, Andy ;
Pereira, Jose H. ;
Rodrigues, Andria V. ;
van Dijk, Alberdina A. ;
Ebrecht, Ana C. ;
Opperman, Diederik J. ;
Sagmeister, Theo ;
Buhlheller, Christoph ;
Pavkov-Keller, Tea ;
Rathinaswamy, Manoj K. ;
Dalwadi, Udit ;
Yip, Calvin K. ;
Burke, John E. ;
Garcia, K. Christopher ;
Grishin, Nick V. ;
Adams, Paul D. ;
Read, Randy J. ;
Baker, David .
SCIENCE, 2021, 373 (6557) :871-+
[5]   Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach [J].
Baggio, Carlo ;
Gambini, Luca ;
Udompholkul, Parima ;
Salem, Ahmed F. ;
Aronson, Alexander ;
Dona, Ada ;
Troadec, Estelle ;
Pichiorri, Flavia ;
Pellecchia, Maurizio .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (14) :6350-6363
[6]   Targeted Covalent Inhibitors for Drug Design [J].
Baillie, Thomas A. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (43) :13408-13421
[7]   Lysosome-targeting chimaeras for degradation of extracellular proteins [J].
Banik, Steven M. ;
Pedram, Kayvon ;
Wisnovsky, Simon ;
Ahn, Green ;
Riley, Nicholas M. ;
Bertozzi, Carolyn R. .
NATURE, 2020, 584 (7820) :291-+
[8]   Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks [J].
Barf, Tjeerd ;
Kaptein, Allard .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (14) :6243-6262
[9]   Bioorthogonal click chemistry: Covalent labeling in living systems [J].
Baskin, Jeremy M. ;
Bertozzi, Carolyn R. .
QSAR & COMBINATORIAL SCIENCE, 2007, 26 (11-12) :1211-1219
[10]   Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies [J].
Bauer, Renato A. .
DRUG DISCOVERY TODAY, 2015, 20 (09) :1061-1073